Back

RxCe.com LLC

  • Prostatic Neoplasms

Prostate Cancer: Interprofessional Collaboration and Pharmacologic Care

Prostate cancer is the most frequently diagnosed cancer among men and a leading cause of cancer-related mortality. Approximately one in eight men will be diagnosed with prostate cancer during their lifetime. Despite advancements in screening and treatment, this condition remains a public health challenge due to its heterogeneity, variable progression, and disparities in outcomes across racial and socioeconomic populations. Within this continuing education activity, participants will review the etiology, risk factors, staging, and diagnosis of prostate cancer. This activity will also review available treatment options, including chemotherapy, hormone therapy, immunotherapy, and emerging agents. Throughout the activity, an emphasis will be placed on interprofessional communication and shared decision-making.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 2 creditsAAPA Category 1 Credit™Up to 2 creditsAMA PRA Category 1 Credit™Up to 2 creditsPharmacyUp to 2 credits

MOC types

ABIM — Medical KnowledgeUp to 2 pointsABIM — Practice AssessmentUp to 2 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

$6.99

$6.99 for 2.00 Contact Hours

Listed by the provider · rxce.com

  • Enduring / On-demand
  • Credit · Up to 2 credits
  • MOC · Up to 2 points
  • $6.99
  • Released
    Mar 18, 2026
  • Last day to claim credit
    Mar 19, 2029 2 years left